share_log
Breakings ·  Aug 7 04:01
Sangamo Therapeutics Q2 Adjusted Operating Expenses USD 31.9 Million
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment